The table below shows AMGEN INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
$2.74B
$3.08B
$3.01B
$2.97B
$3.31B
$3.24B
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
AMGN annual revenue (10-K history)
AMGEN INC reported annual revenue of $36.75B for fiscal year 2025. That is up 10.0% from $33.42B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $22.99B (FY 2016) to $36.75B. Figures come from the company's audited annual reports as filed with the SEC.